←Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer Immunotherapy
Delvys Rodriguez-Abreu
MD, PhD
🏢Complejo Hospitalario Universitario Insular Materno Infantil🌐Spain
Head of Medical Oncology
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Delvys Rodriguez-Abreu co-led the KEYNOTE-189 trial establishing pembrolizumab with platinum-pemetrexed chemotherapy as standard first-line treatment for nonsquamous metastatic NSCLC. She has been an active investigator in multiple KEYNOTE and European lung cancer studies.
Share:
🧪Research Fields 研究领域
KEYNOTE-189
pembrolizumab chemotherapy
nonsquamous NSCLC
thoracic oncology
Spanish lung cancer group
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Delvys Rodriguez-Abreu 的研究动态
Follow Delvys Rodriguez-Abreu's research updates
留下邮箱，当我们发布与 Delvys Rodriguez-Abreu（Complejo Hospitalario Universitario Insular Materno Infantil）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment